Making a Default-alive Techbio Company

Most biotech startups are default dead. In fact, most of them earn zero revenue throughout their entire existence, regardless of how many millions of dollars they raise. This is usually true even after they IPO – most are still many years from being able to sell their therapeutics on the market. For software companies, being default alive vs default dead has a simple definition as articulated by…